Dexamethasone Moxifloxacin recall — Class II (D-0249-2026) · pharmaranks
Class IIOngoing
Dexamethasone Moxifloxacin recall
FDA recall D-0249-2026 · initiated Dec 18, 2025
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of particulate matter - Glass like particles.
Details
Product
Dexamethasone Moxifloxacin, 1 mg/mL and 5 mg/mL, 1 mL Intraocular Injection, Rx only, Imprimis NJOF, LLC, Ledgewood, NJ 07852, NDC 71384-512-0.1
Recalling company
Imprimis NJOF, LLC
Classification
Class II
Status
Ongoing
Type
Voluntary: Firm initiated
Distribution
U.S Nationwide
Initiated
Dec 18, 2025
FDA report date
Jan 14, 2026
What to do.If you have a recalled product, don't throw away questions — check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This page reproduces public FDA data and is not medical advice.